MedTrace Logo

Supervised Exercise During Neoadjuvant Chemotherapy for Breast Cancer

NCT07764341 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2026-08-13

No results posted yet for this study

Summary

The goal of this clinical trial is to learn whether supervised exercise is practical and safe for women receiving chemotherapy before surgery for breast cancer.

The main questions it aims to answer are:

* Can participants attend and complete the supervised exercise program during chemotherapy?
* Is the exercise program safe?
* Does exercise help maintain muscle mass, strength, quality of life, and chemotherapy delivery?

Participants will be assigned to either:

* supervised aerobic and strength exercise during chemotherapy, or
* usual care without a study exercise program. Researchers will compare the two groups before and after chemotherapy.

Conditions

  • Breast Cancer Early Stage Breast Cancer (Stage 1-3)
  • Breast Neoplasm Malignant Female

Interventions

OTHER

Supervised exercise

Supervised combined aerobic and resistance exercise during neoadjuvant chemotherapy, delivered as two supervised sessions per week throughout the course of NACT.

Sponsors & Collaborators

  • Bahrain Oncology Center

    collaborator UNKNOWN

  • King Hamad University Hospital, Bahrain

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-09-30
Primary Completion
2027-09-30
Completion
2027-09-30

Countries

  • Bahrain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07764341 on ClinicalTrials.gov